RL
PureTech Health Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GlyphAllo™ (SPT-300) | Neuropsychiatric disorders | Phase 1b/2a |
| Plenity® | Weight management | Approved |
| LYT-100 (deupirfenidone) | Fibrotic diseases (e.g., IPF) | Phase 2 |
| LYT-200 | Oncology (solid tumors) | Phase 1/2 |
| LYT-300 | Anxiety disorders | Phase 1 |
| LYT-310 | Epilepsy | Preclinical |
| EndeavorRx® | Pediatric ADHD | Approved |
| KarXT (Cobenfy™) | Schizophrenia | Approved |